New Il-2 Sturmovik video:
Slowly developing my (very rudimentary) ground attack skills.
Low level attack in an Ilyushin Il-2 'Sturmovik' 1941 (1 series) armed with RS-82 rockets on German armour approaching Moscow.
Got a bit close to the ground, but happy overall. Definitely need more strike practice, though!
#Gameplay #Aviation #WW2 #EasternFront #GroundAttack #Strike #Il2 #Tanks #Rockets
#rockets #tanks #il2 #strike #groundattack #easternfront #ww2 #Aviation #gameplay
'As of yet, none of the improved IL-2-based compounds gained regulatory approval for the treatment of cancer or autoimmune diseases. Three compounds treating cancer have entered phase 3 trials with two studies still ongoing. NKTR-214 is the only compound that has completed phase 3 studies.'
#Immunology #Immunotherapy #IL2 #Preprint
https://www.medrxiv.org/content/10.1101/2022.12.02.22283042v1
#immunotherapy #il2 #preprint #immunology
"A close examination of the IL-2–IL-2Rα binding interface reveals a putative “pH Switch” consisting of the interaction between Arg38 in IL-2 and His120 in IL-2Rα (Fig. 2F). We hypothesized that, at the low pH in the TME, His120 would become protonated, resulting in release of IL-2 from IL-2Rα and therefore lack of signaling."
#immunology #cytokine #immunotherapy #il2
RT @RoychoudhuriLab@twitter.com
Excited to see this collaboration with @at_Mitralab@twitter.com @LabMoraga@twitter.com finally out! #IL2 is inactivated by acidic pH rendering it poorly effective within acidified tumors. We engineered a pH-resistant IL-2 #mutein selectively active at #acidic #pH. https://www.science.org/doi/10.1126/sciimmunol.ade5686
🐦🔗: https://twitter.com/RoychoudhuriLab/status/1598961234400858112
RT @KevinKXHe@twitter.com
Impressive talk by Prof. Adrian Liston (@LabListon@twitter.com) from @BabrahamInst@twitter.com @Cambridge_Uni@twitter.com on boosting brain #Treg in traumatic brain injury (#TBI) and neurodegeneration.
#IL2 #neuroimmunology #ASI2022MEL @ASImmunology@twitter.com
🐦🔗: https://twitter.com/KevinKXHe/status/1597775573115228162
#treg #tbi #il2 #neuroimmunology #asi2022mel